Severe Doxycycline-Induced Oesophagitis With Granulomatous Inflammation Managed in a Rural Australian Hospital: A Case Report.
Case report
OA: gold
CC-BY-4.0
Abstract
Pill-induced oesophageal injury or pill oesophagitis typically presents with acute retrosternal pain, odynophagia, and dysphagia. While often self-limiting, cases may mimic acute coronary syndrome, food bolus, oesophageal perforation, and mediastinitis. Doxycycline is among the most commonly implicated medications. We report the case of a 32-year-old woman with severe mid-oesophageal ulceration secondary to doxycycline commenced for rosacea, managed at a rural Australian hospital. The histopathology finding of granulomatous inflammation was deemed reactive and secondary to severe ulceration, in the absence of infection or sarcoidosis. The patient was treated supportively with complete clinical and endoscopic resolution. Clinicians should consider pill oesophagitis in patients with acute retrosternal pain and odynophagia after starting doxycycline, and conservative management can be successful.
My notes (saved in your browser only)
Citation neighborhood (no data yet)
We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2026) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.
SciLite annotations
chemicals 32
tetracyclines
pamidronate
potassium chloride
ferrous ammonium sulfate hexahydrate
doxycycline
tetracycline
doxycycline
doxycycline
doxycycline
doxycycline
doxycycline
doxycycline
doxycycline hyclate
gelatin
water
water
sucralfate
doxycycline
doxycycline
doxycycline
sucralfate
water
doxycycline
alcohol
doxycycline
pantoprazole
sucralfate
pantoprazole
doxycycline
doxycycline
doxycycline
doxycycline
organisms 5
noordeloos 2009062
ammonia-oxidizing bacterium
cytomegalovirus
human alphaherpesvirus 1 strain rh2
human
Source provenance
- europepmc
- last seen: 2026-11-15T09:34:25.365398+00:00
- scilite
- last seen: 2026-11-15T10:16:09.319260+00:00
License: CC-BY-4.0
· commercial use OK
· attribution required
Per Europe PMC
Per Europe PMC